Macitentan reduces the risk of morbidity and mortality irrespective of the presence or absence of right ventricular (RV) impairment: Results from the randomised SERAPHIN trial in pulmonary arterial hypertension (PAH)

被引：0
|
作者：
Sitbon, Olivier
Channick, Richard N.
Delcroix, Marion
Ghofrani, Hossein-Ardeschir
Jansa, Pavel
Le Brun, Franck -Olivier
Mehta, Sanjay
Perchenet, Loic
Pulido, Tomas
Rubin, Lewis J.
Sastry, B. K. S.
Simonneau, Gerald
Souza, Rogerio
Torbicki, Adam
Galie, Nazzareno
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2014年 / 44卷
关键词：
Pulmonary hypertension; Treatments; Circulation;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
3419
引用
收藏
页数：5
相关论文
共 18 条
  • [1] Macitentan reduces the risk of morbidity mortality irrespective of the presence or absence of right ventricular (RV) impairment: Results from the randomised SERAPHIN trial in pulmonary arterial hypertension (PAH)
    Sitbon, Olivier
    Channick, Richard N.
    Delcroix, Marion
    Ghofrani, Hossein-Ardeschir
    Jansa, Pavel
    Le Brun, Franck -Olivier
    Mehta, Sanjay
    Perchenet, Loic
    Pulido, Tomas
    Rubin, Lewis J.
    Sastry, B. K. S.
    Simonneau, Gerald
    Souza, Rogerio
    Torbicki, Adam
    Galie, Nazzareno
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [2] Effect of macitentan on morbidity and mortality in pulmonary arterial hypertension: A randomised controlled trial (SERAPHIN)
    Ghofrani, Hossein-Ardeschir
    Channick, Richard
    Delcroix, Marion
    Galie, Nazzareno
    Jansa, Pavel
    Le Brun, Franck-Olivier
    Mehta, Sanjay
    Mittelholzer, Camilla
    Pulido, Tomas
    Sastry, B. K. S.
    Sitbon, Olivier
    Souza, Rogerio
    Torbicki, Adam
    Rubin, Lewis
    Simonneau, Gerald
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [3] Effect of macitentan on haemodynamics in SERAPHIN, a randomised controlled trial in pulmonary arterial hypertension (PAH)
    Sitbon, Olivier
    Channick, Richard
    Delcroix, Marion
    Galie, Nazzareno
    Ghofrani, Hossein-Ardeschir
    Jansa, Pavel
    Le Brun, Franck-Olivier
    Mehta, Sanjay
    Perchenet, Loic
    Pulido, Tomas
    Sastry, B. K. S.
    Souza, Rogerio
    Torbicki, Adam
    Rubin, Lewis
    Simonneau, Gerald
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [4] EFFECT OF MACITENTAN ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PULMONARY ARTERIAL HYPERTENSION (PAH): RESULTS FROM THE SERAPHIN RANDOMISED CONTROLLED TRIAL
    Youssef, P.
    Galie, N.
    Perchenet, L.
    Rubin, L.
    Simonneau, G.
    Mehta, S.
    [J]. INTERNAL MEDICINE JOURNAL, 2014, 44 : 31 - 31
  • [5] Results from the REPAIR Study Final Analysis: Effects of Macitentan on Right Ventricular (RV) Remodelling in Pulmonary Arterial Hypertension (PAH)
    Noordegraaf, A. Vonk
    Channick, R.
    Cottreel, E.
    Kiely, D.
    Martin, N.
    Moiseeva, O.
    Peacock, A.
    Tawakol, A.
    Torbicki, A.
    Rosenkranz, S.
    Galie, N.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S16 - S17
  • [6] EFFECT OF MACITENTAN ON PULMONARY ARTERIAL HYPERTENSION-RELATED HOSPITALISATIONS: RESULTS FROM THE RANDOMISED CONTROLLED SERAPHIN TRIAL
    Coghlan, G.
    Channick, R. N.
    Rubin, L. J.
    Galie, N.
    Perchenet, L.
    Simonneau, G.
    [J]. THORAX, 2013, 68 : A143 - A143
  • [7] Anticoagulant therapy does not influence long-term outcomes in patients with pulmonary arterial hypertension (PAH): insights from the randomised controlled SERAPHIN trial of macitentan
    Galie, N.
    Delcroix, M.
    Ghofrani, H. -A.
    Jansa, P.
    Minai, O. A.
    Perchenet, L.
    Rubin, L. J.
    Sastry, B. K. S.
    Torbicki, A.
    Simonneau, G.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 10 - 10
  • [8] EFFECT OF MACITENTAN ON HAEMODYNAMICS IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: RESULTS FROM THE LONG-TERM, RANDOMISED, PLACEBO-CONTROLLED SERAPHIN TRIAL
    Coghlan, G.
    Torbicki, A.
    Galie, N.
    Rubin, L. J.
    Perchenet, L.
    Simonneau, G.
    [J]. THORAX, 2013, 68 : A26 - A26
  • [9] Effect of macitentan on haemodynamics in patients with pulmonary arterial hypertension: results from the long-term, randomised, placebo-controlled SERAPHIN trial
    Torbicki, A.
    Mehta, S.
    Perchenet, L.
    Pulido, T.
    Sastry, B. K. S.
    Sitbon, O.
    Souza, R.
    Rubin, L. J.
    Simonneau, G.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 : 186 - 186
  • [10] Effect of macitentan on left ventricular (LV) function in pulmonary arterial hypertension (PAH): results from REPAIR
    Rosenkranz, S.
    Channick, R.
    Cottreel, E.
    Galie, N.
    Kiely, D. G.
    Marcus, J. T.
    Swift, A. J.
    Tawakol, A.
    Torbicki, A.
    Noordegraaf, A. Vonk
    Wetherill, G.
    Peacock, A.
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 : 2296 - 2296
12